Single-agent gemcitabine in patients with resistant small-cell lung cancer
I Van der Lee, EF Smit, JWG Van Putten, HJM Groen… - Annals of oncology, 2001 - Elsevier
Objective This study was conducted to assess the activity and toxicity of gemcitabine in
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
Single-agent gemcitabine in patients with resistant small-cell lung cancer
EF Smit, JWG van Putten, HJM Groen… - Annals of …, 2001 - research.rug.nl
Objective: This study was conducted to assess the activity and toxicity of gemcitabine in
patients with resistant small-cell lung cancer (SCLC). Patients and methods: Forty-one …
patients with resistant small-cell lung cancer (SCLC). Patients and methods: Forty-one …
Single-agent gemcitabine in patients with resistant small-cell lung cancer
I van der Lee, EF Smit, JWG van Putten… - Annals of …, 2001 - annalsofoncology.org
Objective This study was conducted to assess the activity and toxicity of gemcitabine in
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
[PDF][PDF] Single-agent gemcitabine in patients with resistant small-cell lung cancer
I van der Lee, EF Smit, JWG van Putten… - Annals of …, 2001 - researchgate.net
Objective This study was conducted to assess the activity and toxicity of gemcitabine in
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
[PDF][PDF] Single-agent gemcitabine in patients with resistant small-cell lung cancer
I van der Lee, EF Smit, JWG van Putten… - Annals of …, 2001 - academia.edu
Objective This study was conducted to assess the activity and toxicity of gemcitabine in
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
patients with resistant small-cell lung cancer (SCLC) Patients and methods Forty-one …
Single-agent gemcitabine in patients with resistant small-cell lung cancer.
I van der Lee, EF Smit, JW van Putten… - Annals of Oncology …, 2001 - europepmc.org
Objective This study was conducted to assess the activity and toxicity ofgemcitabine in
patients with resistant small-cell lung cancer (SCLC). PATIENTS TAND METHODS: Forty …
patients with resistant small-cell lung cancer (SCLC). PATIENTS TAND METHODS: Forty …
Single-agent gemcitabine in patients with resistant small-cell lung cancer
I van der Lee, EF Smit… - Annals of oncology …, 2001 - pubmed.ncbi.nlm.nih.gov
Objective This study was conducted to assess the activity and toxicity ofgemcitabine in
patients with resistant small-cell lung cancer (SCLC). PATIENTS TAND METHODS: Forty …
patients with resistant small-cell lung cancer (SCLC). PATIENTS TAND METHODS: Forty …
[引用][C] Single-agent gemcitabine in patients with resistant small-cell lung cancer
I van der Lee, EF Smit, JWG van Putten, HJM Groen… - Annals of …, 2001 - cir.nii.ac.jp
[引用][C] Single-agent gemcitabine in patients with resistant small-cell lung cancer
I VAN DER LEE, EF SMIT… - Annals of …, 2001 - pascal-francis.inist.fr
Single-agent gemcitabine in patients with resistant small-cell lung cancer CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …
Single-agent gemcitabine in patients with resistant small-cell lung cancer
I Lee, EF Smit, JWG van Putten, HJM Groen… - Annals of …, 2001 - elibrary.ru
Objective: This study was conducted to assess the activity and toxicity of gemcitabine in
patients with resistant small-cell lung cancer (SCLC). Patients and methods: Forty-one …
patients with resistant small-cell lung cancer (SCLC). Patients and methods: Forty-one …